TSHATaysha Gene Therapies, Inc.
6.090USD-5.29%Mkt Cap: 1.98B $P/E: —3d ago
Taysha Gene Therapies, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of severe monogenic diseases of the central ner…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap1.98B $
Enterprise Value1.59B $
Revenue (TTM)5.49M $
Gross Profit5.49M $
Net Income (TTM)-109.00M $
Revenue/Share0.0150 USD
Last Price6.090 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees99
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-12.80
PEG—
EV/EBITDA-10.47
EV/Revenue290.27
P/S362.96
P/B8.28
EPS (TTM)-0.39
EPS (Forward)-0.48
52W Range
2.71174% of range7.300
52W High7.300 USD
52W Low2.711 USD
Profitability
Gross Margin100.00%
Oper. Margin-2792.32%
EBITDA Margin0.00%
Profit Margin-1115.27%
ROE-44.14%
ROA-31.75%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-93.09M $
CapEx (TTM)738.00K $
FCF Margin-1476.13%
FCF Yield-4.08%
Net Debt-398.69M $
Net Debt/EBITDA2.62
Balance Sheet
Debt/Equity0.28
Current Ratio17.77
Quick Ratio17.53
Book Value/Sh0.7380 USD
Cash/Share1.398 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)13.33 USD
Upside (mean)+118.9%
Target Range10.00 USD – 19.00 USD
$10.00+118.9% to mean$19.00
# Analysts12
Ownership
Shares Out.325.83M
Float232.62M
Insiders9.45%
Institutions94.20%
Short Interest
Short Ratio15.1d
Short % Float14.83%
Short % Out.14.60%
Shares Short46.69M
Short (prev mo.)41.40M
Technical
SMA 506.130 (-0.6%)
SMA 2005.344 (+14.0%)
Beta1.19
S&P 52W Chg18.16%
Avg Vol (30d)2.63M
Avg Vol (10d)2.97M
Technical Indicators
RSI (14)49.4
MACD0.0668
MACD Signal0.0610
MACD Hist.+0.0059
BB Upper6.800 USD
BB Middle6.058 USD
BB Lower5.316 USD
BB Width24.49%
ATR (14)0.3961 USD
Vol Ratio (20d)0.58x